Videos

An interview on new survey data suggesting a majority of fertility and pregnant patients are not interested in the currently available vaccines.

The ability to monitor, mitigate, and prevent new variant spread could influence the odds of majority immunity.

More transmissible variants are emerging quickly. An expert explains why it's expected, but concerning.

Athersys has developed its MultiStem cell therapy for COVID-19 Acute respiratory distress syndrome (ARDS). Athersys CEO Gil Van Bokkelen, PhD, and CFO Ivor Macleod, recently spoke to Contagion providing background on the company and their MultiStem therapy.

In consideration of the idea that the pandemic may lead to greater knowledge and adoption of preventive health measures.

Perspective on the ongoing independent safety reviews for one of the more promising vaccine candidates.

Within NIH is the National Center for Advancing Translational Sciences (NCATS) and they will oversee the grant awards. Christopher Austin, MD, director, NCATS, discusses the specifics of the 2 trials being expanded.

Fauci also shares suggestions for college campus to mitigate community-based spread while classes continue.

A discussion with an expert on the particularities of the vaccines, which vary in temperature climate requirements and dosages.

Aethlon Medical is developing its proprietary Hemopurifier, which is a therapeutic device designed for the single use depletion of circulating viruses.

Brad Spellberg, MD, emphasizes his belief the Affordable Care Act needs to be retained so as long as the pandemic persists.

Principal investigator Richard Becker, MD, director of the University of Cincinnati Heart, Lung and Vascular Institute discusses the phase 2 clinical trial for razuprotafib.

The country is split on certain strategies and a potential vaccine. Here's why the message needs to go from national to regional.

Brad Spellberg, MD, describes the inconsistent, impersonal messaging given to the public as cases begin to rise again.

Dr. Rodney E. Rohde, clinical laboratory scientist, discusses campus reopening as well as his work on rabies eradication.

Is it still safe to take your child to get a vaccine during the pandemic? According to experts, there are safety measures in place for this critically important task.

Dr. Debra Goff describes the rush to "Just in Case" prescribing of antibiotics early in the COVID-19 pandemic, when less was known about the clinical course of the disease.

A pediatric cardiologist discusses the specifics of a case study, the importance of adaptability, and how her healthcare system has developed treatment protocols in these cases.

What the AstraZeneca vaccine research pause meant for physician-patient discussion on vaccine candidate safety.

A health data analytics expert describes how repeat or low-value studies can arise amid the rush to publish pandemic research.

MediFind's Patrick Howie examines the consolidation of resources during pandemics amid concerns that funding will not return to other areas of health research.

What we've seen non-immunized communities do for previously eradicated outbreaks.

Incredible resources and effort have been put into the COVID-19 response, but other infectious disease priorities have also been displaced. Patrick Howie, CEO of a firm which aggregates clinical analysis and data, explains.

University of Maryland professor of medical technology answers where limited testing resources ought to be directed given pandemic supply issues.

University of Maryland professor of medical technology explains the ways speed and accuracy are weighed when testing is deployed to detect COVID-19.

A discussion with an Ohio State investigator on early CMR findings among young athletes.

Robert H. Christenson, PhD, University of Maryland, outlines the incentives for how SARS-CoV-2 testing reagents are acquired by institutions.

Robert H. Christenson, PhD, outlines the ways SARS-CoV-2 transmission is prevented during testing, how testing materials are acquired, and more.